Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Alex Kentsis
pediatric leukemias
Simona Colla
Myeloma biology
Ana Vujovic
AML
Catherine Bollard
pediatric blood cancers and immunotherapy
Leandro Cerchietti
DLBCL
Venkata Lokesh Battula
immunotherapy and AML
Martin Dreyling
Mantle Cell Lymphoma
Wendy Béguelin
follicular lymphoma
Srividya Swaminathan
pediatric, immunotherapy
Kasey Leger
pediatric blood cancers
Roland Walter
Antibody-based AML therapies
Markus Muschen
leukemia and lymphoma biology
Oreofe Odejide
Equity in Access
Dan Landau
cancer evolution biology
Koichi Takahashi
AML/MDS
Wendy Stock
T-cell ALL
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Michaela Reagan
Multiple Myeloma
Craig Jordan
AML
Jaroslaw Maciejewski
bone marrow failure
Nizar Bahlis
Myeloma immunotherapy
Elliot Stieglitz
CMML
Carl Allen
pediatric blood cancers
Jalpa Doshi
Equity in Access
Jianguo Tao
Mantle Cell Lymphoma
H. Irene Su
Equity in Access
Xu Ji
Equity in Access
Jake Shortt
precision therapy for aggressive lymphomas
Alfred Garfall
myeloma immunotherapy
Jolanta Grembecka
leukemia therapeutics
Brian Dalton
DNA mutations and myeloid cancers
Sarah Tasian
pediatric leukemias
Areej El-Jawahri
transplant survivorship
Nicoletta Cieri
AML and transplantation
Daniel Lucas
bone marrow and leukemia biology
Mark Hamilton
DLBCL and CAR-T
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Anthony Letai
improving CAR-T
Siegfried Janz
Myeloma immunotherapy
Ricky Johnstone
lymphoma and myeloma
Daniel Starczynowski
MDS and AML
Adam Olszewski
Follicular and marginal zone lymphoma
Stephen Oh
myeloproliferative neoplasms
ImCheck Therapeutics
immunotherapy, AML
Catherine Smith
leukemia
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
John Crispino
MPNs, myelofibrosis
Catherine Diefenbach
DLBCL immunology
Rizwan Romee
Immunotherapy
Kerry Rogers
CLL
Joachim Yahalom
Lymphoma
Sheng Li
Aging and AML
Noemí Puig Morón
Myeloma
Sisi Chen
leukemia
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Christian Steidl
B-cell lymphomas
Lindsey Montefiori
pediatric leukemia
Mendel Goldfinger
MDS/AML trials for the elderly
Justine Kahn
pediatric leukemia and lymphoma
Stephen Nimer
myeloid cancer biology
Christopher Booth
BPDCN
Hao Jiang
DNA biology and leukemia
Caroline Arber
myeloma CAR-T
Helen Parsons
Equity in Access
Michael Savona
MDS and leukemia
Jean Koff
Disparities in DLBCL
Teresa Palomero
Peripheral T-cell Lymphoma
Courtney DiNardo
clinical trials, AML
Nirav Shah
CAR-T for lymphoma
Sigurður Kristinsson
Smoldering myeloma
Bingyi Chen
AML immunotherapy
Timothy Graubert
AML and MDS biology
John DiPersio
trispecific antibody for AML and MDS
Madhav Dhodapkar
multiple myeloma immunotherapy
Matteo Bellone
Smoldering multiple myeloma
Rgenta Therapeutics
RNA-targeting, blood cancer
Grant Challen
preleukemia, leukemia
Richard Lock
T-ALL
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Kura Oncology
MLL leukemia, AML
Sergei Doulatov
Leukemias
Michael Wang
Mantle Cell Lymphoma
Meng Li
Equity in Access
Ronald Levy
immunotherapies, COVID-19
Nataly Cruz-Rodriguez
T-ALL and metabolism
Jessica Stewart
Epstein-barr virus and lymphomas
Lucy Godley
preleukemia
Sahand Hormoz
MPN
Gaurav Goyal
Erdheim-Chester Disease
Robert Soiffer
transplantation
Jennifer Trowbridge
aging and leukemia
Margaret Shipp
lymphoma biology
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Gareth Morgan
smoldering myeloma, MGUS
Tycel Phillips
Mantle Cell Lymphoma
Luca Busino
DLBCL
F. Lennie Wong
Equity in Access
Liran Shlush
pre-leukemia
Randall Davis
CLL
John Leonard
lymphoma research
Bing Carter
p53 mutant AML
Peter Klein
MDS
Roberta Zappasodi
lymphoma, immunotherapy
Michael Green
lymphoma biology
Lori Muffly
Equity in Access
Alexey Danilov
lymphoma
Reina Takeda
AML
Jonathan Licht
DNA biology, myeloma
Amin Sobh
Myeloma biology
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Neha Mehta-Shah
T-cell lymphoma
Julia Paczkowska
immunobiology of Hodgkin's disease
Inhye Ahn
CLL
Frederick Locke
lymphoma and immunotherapy
Tanya Siddiqi
clinical trial access
Faron Pharmaceuticals
immunotherapy, MDS
Coleman Lindsley
AML/MDS
Jing Yang
Myeloma
Jianhua Yu
myeloma immunotherapy
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Bruno Paiva
smoldering myeloma
Frederike Kramer
MPNs
Adam de Smith
pediatric ALL and Down Syndrome
Bailee Kain
AML and African ancestry
Rong Lu
preleukemia, leukemia
Siddhartha Jaiswal
preleukemia
Alec Zhang
myeloma, immunotherapy
Stephen Gottschalk
pediatric leukemia and CAR-T
Jennifer Woyach
CLL trials
Alison Moskowitz
lymphoma therapeutics
Thomas Kipps
Hairy Cell Leukemia
Thomas Koehnke
leukemia
Yibin Yang
Lymphoma
Peter Croucher
Multiple Myeloma
Courtney Jones
AML metabolism
Eugenio Morelli
Myeloma
Tak Mak
Immunotherapy
Kathleen Sakamoto
pediatric AML
Kirk Schultz
pediatric transplantation
Nicola Vannini
Aging and CAR-T success
Yubin Zhou
peripheral T cell lymphoma
Taishi Yonezawa
AML
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Jayna Mistry
aging and leukemias
Qing Yi
Novel CAR-T
Maximilian Stahl
AML immunotherapy
Sham Mailankody
Myeloma immunotherapy clinical trials
Daniel Pollyea
AML
Eric Pietras
AML
Anouchka Laurent
T-cell lymphoma
Fahmin Basher
transplant and GvHD
Britta Will
Leukemia and pre-leukemia
Jeetayu Biswas
splicing in myeloid diseases
Daisuke Nakada
preleukemia, leukemia
Grzegorz Nowakowski
Clinical trial access
Tomasz Skorski
myeloproliferative neoplasms, AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Paolo Caimi
CAR-T clinical trial for CLL
Saar Gill
AML immunotherapy
Lawrence Boise
CART and myeloma
Adi Nagler
Bronchiolitis obliterans after transplant
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Suman Paul
T cell cancers and immunotherapy
Thomas LeBlanc
palliative care
BioInvent International
immunotherapy, indolent NHL, CTCL
William Matsui
Myeloma
Christine Zhang
AML
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Mark Murakami
follicular lymphoma
Jonas Jutzi
myeloproliferative neoplasms
Christopher Porter
Leukemia, lymphoma
Armin Rashidi
gut bacteria and transplant success
Christopher Flowers
clinical trial access
Daniel Thomas
Myelofibrosis
Gianpietro Dotti
CAR T and AML
Jaehyuk Choi
T-cell lymphoma
Michael Kharas
leukemia
Jing Fu
myeloma
Jeremy Baeten
AML
Michael Keller
COVID-19, immunotherapy
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Catriona Jamieson
cancer stem cell biology
Trent Hall
MDS
Steven Horwitz
T-cell lymphomas
Takeshi Sugio
T-cell lymphoma
Qingyu Luo
BPDCN
Jonathon Cohen
lymphoma clinical trial access in Georgia
Alieen Rowan
Adult T cell leukemia/lymphoma
Ruben Carrasco
Myeloma
Dane Vassiliadis
blood cancer biology
Brian Walker
smoldering myeloma, MGUS
Piers Patten
COVID-19
Yoke Seng Lee
AML
George Vassiliou
Leukemia Prevention
Marina Konopleva
MDS/AML metabolism
Ravi Bhatia
transplantation
Soheil Meshinchi
pediatric AML
Nitin Jain
CLL
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Eirini Papapetrou
blood cancer stem cells
Philippe Armand
follicular lymphoma
Susan Schwab
cancer immunology
Yan Liu
MDS
Mark Dawson
B-ALL and CAR-T resistance
Eric Padron
CMML
Lakshmi Nayak
brain tumors in lymphoma
Omar Abdel-Wahab
Hairy cell leukemia
Pooja Khandelwal
bone marrow transplantation
Andrew Lane
BPDCN
Fenghuang Zhan
Myeloma and bone disease
Logan Spector
childhood leukemia epidimiology
Keisuke Ito
blood cancer stem cells and MDS metabolism
Suzanne Lentzsch
Myeloma
Kimberly Stegmaier
childhood blood cancers
Liling Wan
AML
Christian Marinaccio
MLL leukemias
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Daniel Herranz
T-ALL
Carl June
CAR T immunotherapy
Megan McNerney
AML/MDS
Mala Shanmugam
myeloma
Lev Kats
myeloma and epigenetics
Dimericon Therapeutics
dimericons, blood cancer
Matthew Frank
Lymphoma CART therapy
Caner Saygin
T-ALL
Paolo Strati
Non-Hodgkin Lymphoma
Marc Seifert
Hairy cell leukemia
Steven Treon
Lymphomas and Waldenstrom's
Hong Wen
AML
Marco Ruella
Immunotherapy for T-cell lymphoma
Sam Butterworth
CMML
Ari Melnick
epigenetics and lymphoma
Ann-Kathrin Eisfeld
Racial diversity in AML
Nicolas Nassar
pediatric leukemia
Ravindra Majeti
preleukemia, AML
Carma Bylund
Equity in Access
Yiman Liu
Epigenetics and leukemia
Pietro Genovese
transplant and AML
Shazia Nakhoda
Equity in Access
Solu Therapeutics
immunotherapy, CMML
Affimed
immunotherapy, HL, PTCL
Enterome
vaccine, FL, MZL
Cailin Collins
Leukemia and pre-leukemia
Anushree Vichare
Equity in Access
Manyi Wei
acute megakaryoblastic leukemia
Constellation Pharmaceuticals
myeloproliferative neoplasms
Raymond Mailhot
Equity in Access
James Rubenstein
Lymphoma of the Central Nervous System
Huda Salman
CMML
Steven Park
follicular lymphoma
Jun Qi
Myeloma
Julia Maxson
AML
Rajni Kumari
AML
Stacie Dusetzina
Equity in Access
Jenny Wang
AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
George Daley
"off-the-shelf" CAR-T and CAR-NK
Tyler Parsons
MPN and AML
Caron Jacobson
lymphoma and immunotherapy
Enrico Tiacci
Hairy cell leukemia
Arash Alizadeh
blood cancer biology and diagnosis
Sriram Sundaravel
AML stem cells
Shannon Maude
Immunotherapy for ALL
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Amit Verma
AML/MDS
Jeffrey Magee
pediatric AML
Ryan Wilcox
T-cell lymphoma
Robert Orlowski
(Smoldering) Multiple Myeloma
Paul Beavis
immunotherapy in myeloma